NIH Launches Program to Help Start-Up Companies License Medical Technologies
President Obama has announced the launch of a new NIH initiative to help start-up companies license groundbreaking medical technologies for drugs, vaccines, and devices developed by in-house NIH scientists. NIH is reducing both the cost and paperwork to obtain an exclusive option to license patents and patent applications from the intramural research labs at both NIH and FDA. NIH Director Francis Collins said the new program will facilitate the transfer of advances from bench to bedside.
Companies that are less than five years old, have fewer than 50 employees and have received investment of less than $5 million are eligible to use these new start-up license agreements. Starting on Oct. 1, biomedical entrepreneurs will be able to apply for any available patents or patent applications by submitting a business plan showing how they plan to use them. More.